These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8453319)

  • 41. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is citrate an inhibitor of calcium oxalate crystal growth in high concentrations of urine?
    Bek-Jensen H; Fornander AM; Nilsson MA; Tiselius HG
    Urol Res; 1996; 24(2):67-71. PubMed ID: 8740974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors in urinary calcium oxalate stone formation and their relation to urinary calcium oxalate supersaturation.
    Ogawa Y; Hatano T
    Int J Urol; 1996 Sep; 3(5):356-60. PubMed ID: 8886911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of trace metals on the inhibition of calcium oxalate crystallization.
    Muñoz JA; Valiente M
    Urol Res; 2005 Aug; 33(4):267-72. PubMed ID: 15937709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kinetics of calcium oxalate crystal formation in urine.
    Laube N; Klein F; Bernsmann F
    Urolithiasis; 2017 Apr; 45(2):151-157. PubMed ID: 27328814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate.
    Fleming DE; Van Riessen A; Chauvet MC; Grover PK; Hunter B; van Bronswijk W; Ryall RL
    J Bone Miner Res; 2003 Jul; 18(7):1282-91. PubMed ID: 12854839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Urine saturation with calcium oxalate in urolithiasis].
    Bogado CE; Zanchetta JR
    Medicina (B Aires); 1988; 48(1):39-44. PubMed ID: 3216787
    [No Abstract]   [Full Text] [Related]  

  • 49. Agglomeration of calcium oxalate monohydrate in synthetic urine.
    Grases F; Masárová L; Söhnel O; Costa-Bauzá A
    Br J Urol; 1992 Sep; 70(3):240-6. PubMed ID: 1422681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of different diets on urine composition and the risk of calcium oxalate crystallisation in healthy subjects.
    Siener R; Hesse A
    Eur Urol; 2002 Sep; 42(3):289-96. PubMed ID: 12234515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion.
    Miyake O; Kakimoto K; Tsujihata M; Yoshimura K; Takahara S; Okuyama A
    Urology; 2001 Sep; 58(3):493-7. PubMed ID: 11549512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis.
    Grases F; Genestar C; Conte A; March P; Costa-Bauzá A
    Br J Urol; 1989 Sep; 64(3):235-7. PubMed ID: 2553195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A study of crystallization on urolithiasis in vitro].
    Miyazawa K; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1991 Oct; 37(10):1091-6. PubMed ID: 1721765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation.
    Berg C; Larsson L; Tiselius HG
    J Urol; 1992 Sep; 148(3 Pt 2):979-85. PubMed ID: 1507355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.
    Chung J; Granja I; Taylor MG; Mpourmpakis G; Asplin JR; Rimer JD
    Nature; 2016 Aug; 536(7617):446-50. PubMed ID: 27501150
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of sodium citrate, potassium citrate, and citric acid in preventing experimental calcium oxalate urolithiasis in rats.
    Ogawa Y; Tanaka T; Yamaguchi K; Morozumi M; Kitagawa R
    Hinyokika Kiyo; 1987 Nov; 33(11):1772-7. PubMed ID: 3445859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ascorbic acid in idiopathic recurrent calcium urolithiasis in humans--does it have an abettor role in oxalate, and calcium oxalate crystallization?
    Schwille PO; Schmiedl A; Herrmann U; Manoharan M; Fan J; Sharma V; Gottlieb D
    Urol Res; 2000 Jun; 28(3):167-77. PubMed ID: 10929425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [*calcium-oxalate lithogenesis: crystallization in the presence of urine from healthy subjects].
    Beaufays JP; Bouche R; Boistelle R
    Nephrologie; 1995; 16(4):325-31. PubMed ID: 7630471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of seed crystals of hydroxyapatite and brushite on the crystallization of calcium oxalate in undiluted human urine in vitro: implications for urinary stone pathogenesis.
    Grover PK; Kim DS; Ryall RL
    Mol Med; 2002 Apr; 8(4):200-9. PubMed ID: 12149569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.